2015-2017- Modified Stage 2- Objectives

From Galen Healthcare Solutions - Allscripts TouchWorks EHR Wiki
Revision as of 19:26, 16 October 2015 by Christyerickson (talk | contribs) (Created page with "=Eligible Providers= There are a total of ten (10) Objectives in the Modified 2015-2017 Stage 2 Program. Below is a description of each objective with exclusions or alternati...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Eligible Providers

There are a total of ten (10) Objectives in the Modified 2015-2017 Stage 2 Program. Below is a description of each objective with exclusions or alternative options following the CMS guidelines[1].

Objective 1- Protect Patient Health Information

Protect electronic health information created or maintained by the CEHRT through the implementation of appropriate technical capabilities.

  • Measure: Conduct or review a security risk analysis in accordance with the requirements in 45 CFR 164.308(a)(1), including addressing the security (to include encryption) of ePHI created or maintained by CEHRT in accordance with requirements under 45 CFR 164.312(a)(2)(iv) and 45 CFR 164.306(d)(3), and implement security updates as necessary and correct identified security deficiencies as part of the EP, eligible hospital, or CAH's risk management process.

Performed annually, no change from previous Stage 1/Stage 2 requirements.

Objective 2- Clinical Decision Support

Use clinical decision support to improve performance on high-priority health conditions.

  • Measure 1: Implement five clinical decision support interventions related to four or more clinical quality measures at a relevant point in patient care for the entire EHR reporting period. Absent four clinical quality measures related to an EP, eligible hospital’s or CAH's scope of practice or patient population, the clinical decision support interventions must be related to high-priority health conditions.
  • Measure 2: The EP, eligible hospital, or CAH has enabled and implemented the functionality for drug-drug and drug allergy interaction checks for the entire EHR reporting period.

There is an exclusion as well as an alternate objective and measure for Stage 1 providers in 2015.